Levtam 250 Tablet contains Levetiracetam 250 mg, an antiepileptic medication indicated for the treatment of partial onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures in patients with epilepsy. Levetiracetam acts by modulating synaptic neurotransmitter release through binding to the synaptic vesicle protein SV2A, which is believed to inhibit nerve conduction across synapses and reduce seizure activity. This medication is commonly prescribed as adjunctive therapy in adults and pediatric patients aged one month and older. Levtam 250 is well-absorbed orally, with rapid onset of action and minimal hepatic metabolism, reducing the risk of drug interactions. Dosage should be individualized based on patient response and clinical condition, with careful titration to minimize adverse effects. Common side effects include somnolence, dizziness, fatigue, and behavioral changes such as irritability or mood swings. Caution is advised in patients with renal impairment, as dose adjustment may be necessary. Levtam 250 should be used under medical supervision, and abrupt discontinuation is discouraged due to the potential risk of increased seizure frequency. Regular monitoring and follow-up are essential to ensure therapeutic efficacy and safety.